期刊文献+

获得性噬血细胞综合征15例临床分析 被引量:4

Clinical characteristics of 15 patients with acquired hemophagocytic syndrome
下载PDF
导出
摘要 目的:探讨获得性噬血细胞综合征(aHPS)的临床特点,为其临床诊断及治疗提供有效的参考资料。方法:回顾性分析15例aHPS患者的临床特点、实验室检查结果、治疗及预后。结果:15例患者均有发热,脾肿大,部分肝肿大、淋巴结肿大、肝肾功能损害、消化道出血症状。实验室检查均有不同程度的血细胞减少、肝功能异常,高甘油三脂血症、铁蛋白>1 000 ng/ml,部分NK细胞活性下降、低纤维蛋白原血症、细胞因子升高。骨髓检查可见噬血现象。通常采用积极治疗原发病、大剂量使用丙种球蛋白和糖皮质激素及依托泊苷的疗法。15例患者除1例失访外,均在1~6周内死亡。结论 :aHPS病因以淋巴瘤居多,病情凶险,预后差,病死率极高,早期诊断,早期治疗,可望提高患者的生存率。 Objective: To investigate the clinical features of acquired hemophagocytic syndrome(a HPS) and provide an available reference for its clinical diagnosis and treatment. Methods: The clinical features, laboratory findings and outcomes of 15 patients with a HPS were retrospectively analyzed. Results: The fever and splenomegaly appeared in all patients while the clinical characteristics such as hepatomegaly, lymphadenopathy, the injury of liver and kidney and the gastrointestinal bleeding symptoms were found only in some patients. There were cytopenia, liver dysfunction, hypertriglyceridemia, serum ferritin 1 000 ng/ml, partly decrease of NK cell activity, hypofibrinogenemia and increase of cytokines to a certain degree in laboratory tests and hemophagocytosis was seen in bone marrow examinations in all patients. They were generally treated with high doses of gamma globulin and corticosteroids and etoposide and meanwhile their primary diseases were also actively treated. Fourteen cases of the patients died within 1~6 weeks in addition to one case of the lost follow-up. Conclusion: AHPS is mostly caused by lymphoma and is one of the dangerous diseases with extremely poor prognosis and high mortality. The survival rate of patients can be improved by early diagnosis and treatment.
出处 《上海医药》 CAS 2017年第1期55-58,共4页 Shanghai Medical & Pharmaceutical Journal
关键词 噬血细胞综合征 获得性 临床特点 shemophagocytic syndrome acquired clinical characteristics
  • 相关文献

参考文献1

二级参考文献23

  • 1Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment [J]. Hematology Am Soc Hematol Educ Program, 2013, 2013:605-611. 被引量:1
  • 2Jordan MB, Allen CE, Weitzman S, et al. How I treat hemo- phagocytic lymphohistiocytosis [ J ]. Blood, 2011, 118 ( 15 ) :4041 - 4052. 被引量:1
  • 3Palazzi DL, McClain KL, Kaplan SL. Hemophagocytic syndrome in children: an important diagnostic consideration in fever of unknown origin [ J]. Clin Infect Dis, 2003, 36 ( 3 ):306- 312. 被引量:1
  • 4Henter JI, Home A, Aric6 M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J]. Pediatr Blood Cancer, 2007, 48(2):124-131. 被引量:1
  • 5Trottestam H, Home A, Aric6 M, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol [ J ]. Blood, 2011, 118 ( 17 ) :4577- 4584. 被引量:1
  • 6Allen CE, Yu X, Kozinetz CA, et al. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis [J]. Pediatr Blood Cancer, 2008, 50 (6):1227- 1235. 被引量:1
  • 7Schram AM, Campigotto F, Mullally A, et al. Marked hyperferri- tinemia does not predict for HLH in the adult population [J]. Blood, 2015, 125( 10):1548-1552. 被引量:1
  • 8Nikiforow S, Berliner N. The unique aspects of presentation and diagnosis of hemophagocytic lymphohistiocytosis in adults [J]. Hematology Am Soc Hematol Educ Program, 2015, 2015:183- 189. 被引量:1
  • 9Tabata C, Tabata R. Possible prediction of underlying lympho- ma by high sIL-2R/ferritin ratio in hemophagocytic syndrome [J]. Ann Hematol, 2012, 91 (1):63-71. 被引量:1
  • 10Tsuji T, Hirano T, Yamasaki H, et al. A high sIL-2R/ferritin ratiois a useful marker for the diagnosis of lymphoma- associated hemophagocytic syndrome [J]. Ann Hematol, 2014, 93 (5):821- 826. 被引量:1

共引文献18

同被引文献21

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部